| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735) | Alaunos Therapeutics | 2022-04-04 |
| A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African Ancestry (NCT05351047) | AstraZeneca | 2022-04-04 |
| Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria (NCT05287893) | Medicines for Malaria Venture | 2022-04-04 |
| Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer (NCT05267626) | Aulos Bioscience, Inc. | 2022-04-04 |
| Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites (NCT05303844) | Fudan University | 2022-04-02 |
| ERK Inhibitor JSI-1187 in Advanced Solid Tumors (NCT06239623) | JS InnoPharm, LLC | 2022-04-02 |
| A Study of CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma (NCT05325801) | Zhejiang University | 2022-04-01 |
| Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial. (NCT05920512) | Xue-chun Lu | 2022-04-01 |
| Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors (NCT05153096) | NovaRock Biotherapeutics, Ltd | 2022-04-01 |
| Stem Cells for the Treatment of Pouchitis (NCT05578508) | The Cleveland Clinic | 2022-04-01 |
| PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer (NCT05325684) | The Affiliated Hospital of Qingdao University | 2022-04-01 |
| Perio. Maint. With Diode LBR (NCT05276817) | Biolase Inc | 2022-04-01 |
| An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment (NCT05051644) | VA Office of Research and Development | 2022-04-01 |
| Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC (NCT04605913) | Mayo Clinic | 2022-04-01 |
| Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers (NCT05689983) | Washington University School of Medicine | 2022-04-01 |
| A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2) (NCT05181501) | Nanjing IASO Biotechnology Co., Ltd. | 2022-04-01 |
| BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE) (NCT05474885) | iCell Gene Therapeutics | 2022-04-01 |
| Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status (NCT05264142) | University Hospital, Geneva | 2022-04-01 |
| Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis (NCT05072886) | Azora Therapeutics Australia Pty Ltd | 2022-04-01 |
| HCW9218 in Select Advanced Solid Tumors (NCT05322408) | Masonic Cancer Center, University of Minnesota | 2022-04-01 |
| Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease (NCT04912427) | Washington University School of Medicine | 2022-04-01 |
| A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05165849) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2022-04-01 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors (NCT05344742) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-04-01 |
| Effect of Cryotherapy Versus Post-operative Ibuprofen Medication on Post-operative Pain in Mandibular Molar Teeth With Symptomatic Irreversible Pulpitis (NCT05341999) | Cairo University | 2022-04-01 |
| Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A (NCT05265767) | Christian Medical College, Vellore, India | 2022-04-01 |
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% (NCT05461456) | OrchestratePharma GmbH | 2022-04-01 |
| Clinical Applications of (S)-[18F]FBFP PET/CT in Healthy Volunteers and Patients With Central Nervous System Diseases (NCT05335200) | Peking Union Medical College Hospital | 2022-04-01 |
| A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. (NCT05320874) | Xuanzhu Biopharmaceutical Co., Ltd. | 2022-04-01 |
| Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P) (NCT03834909) | Johns Hopkins University | 2022-04-01 |
| Intradermal Fractional Dose IPV (fIPV) in Combination With dmLT (NCT05327426) | University of Vermont | 2022-04-01 |
| Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration (NCT04919096) | Clover Biopharmaceuticals AUS Pty | 2022-04-01 |
| Topical Insulin for Glaucoma (NCT05206877) | Stanford University | 2022-04-01 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (NCT05309213) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-04-01 |
| Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML) (NCT05488132) | Xuzhou Medical University | 2022-04-01 |
| Bioavailability of Tebipenem (SPR994) Crushed Tablet (NCT05296382) | Hartford Hospital | 2022-04-01 |
| A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC (NCT05317325) | Sichuan University | 2022-04-01 |
| Synovial Tissue and Fat Pad Stromal Vascular Fraction Bioengineering in Patients With Knee Articular Cartilage Injury (NCT05120700) | University of Sao Paulo General Hospital | 2022-04-01 |
| Biomarker Study: Heart Failure Patients at Risk (NCT05336175) | University of Arizona | 2022-04-01 |
| Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency (NCT05345418) | Vinmec Research Institute of Stem Cell and Gene Technology | 2022-04-01 |
| Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers (NCT05296564) | Hadassah Medical Organization | 2022-04-01 |
| Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL (NCT04872478) | Meryx, Inc. | 2022-04-01 |
| Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults (NCT04983030) | Boris Juelg, MD PhD | 2022-04-01 |
| To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects (NCT05340530) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-04-01 |
| A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants (NCT05320302) | H. Lundbeck A/S | 2022-03-31 |
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers (NCT04916236) | The Netherlands Cancer Institute | 2022-03-31 |
| Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations (NCT05256290) | Black Diamond Therapeutics, Inc. | 2022-03-31 |
| Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer (NCT05303090) | Fudan University | 2022-03-31 |
| A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer (NCT05274893) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2022-03-31 |
| A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors (NCT05159700) | Zhuhai Yufan Biotechnologies Co., Ltd | 2022-03-31 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma (NCT05278975) | RS Oncology LLC | 2022-03-31 |
| A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas (NCT05374226) | Suzhou Kebo Ruijun Biotechnology Co., Ltd | 2022-03-31 |
| Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma (NCT05525286) | SOTIO Biotech a.s. | 2022-03-31 |
| FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation (NCT05246618) | iCoat Medical AB | 2022-03-31 |
| A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects (NCT05208814) | Vigonvita Life Sciences | 2022-03-31 |
| Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques (NCT05642182) | SFA Therapeutics | 2022-03-31 |
| A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803 (NCT05286281) | Pfizer | 2022-03-31 |
| Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT (NCT04959903) | Smart Immune SAS | 2022-03-31 |
| Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA) (NCT05137314) | Peptilogics | 2022-03-31 |
| A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors (NCT05298592) | Bristol-Myers Squibb | 2022-03-31 |
| Effect of Oral Microbiota on MDRO Decolonization (NCT07496502) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2022-03-31 |
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381) | Mayo Clinic | 2022-03-31 |
| To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects (NCT05108259) | Prestige Biopharma Limited | 2022-03-30 |
| Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer (NCT05257993) | Onconic Therapeutics Inc. | 2022-03-30 |
| Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer (NCT05062980) | Genprex, Inc. | 2022-03-30 |
| A Study in Tanzania of a New Vaccine Against Two Types of Ebola (NCT05301504) | University of Oxford | 2022-03-30 |
| A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals (NCT05208125) | IrsiCaixa | 2022-03-30 |
| A Study of LY3841136 in Healthy and Overweight Participants (NCT05295940) | Eli Lilly and Company | 2022-03-30 |
| Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors (NCT05320640) | Chinese PLA General Hospital | 2022-03-30 |
| An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143 (NCT05199610) | EQRx International, Inc. | 2022-03-30 |
| Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause (NCT05325775) | Acer Therapeutics Inc. | 2022-03-30 |
| MMV533 Plasmodium Falciparum Volunteer Infection Study (NCT05205941) | Medicines for Malaria Venture | 2022-03-30 |
| Safety, Tolerability, and Pharmacokinetics Study of ATH-1020 (NCT05169671) | LeonaBio | 2022-03-30 |
| Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults (NCT04645147) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-29 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations (NCT05242822) | Kinnate Biopharma | 2022-03-29 |
| A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors (NCT05508373) | Suzhou Kebo Ruijun Biotechnology Co., Ltd | 2022-03-29 |
| Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects (NCT05298332) | Antios Therapeutics, Inc | 2022-03-29 |
| Assess Fibrin in Brains With AD/ADRD (NCT05336695) | Massachusetts General Hospital | 2022-03-29 |
| JS001+IMP4297 in Patients With Advanced Cancer (NCT05262842) | Shanghai Junshi Bioscience Co., Ltd. | 2022-03-29 |
| A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) (NCT05267470) | Amgen | 2022-03-29 |
| Study in Healthy Adult Female Subjects (NCT05339633) | InventisBio Co., Ltd | 2022-03-29 |
| A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451) | Lyell Immunopharma, Inc. | 2022-03-29 |
| A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer (NCT05657418) | Shanghai Junshi Bioscience Co., Ltd. | 2022-03-29 |
| Efficacy of Cilostazol in Prevention of Peripheral Neuropathy (NCT05298696) | Mansoura University | 2022-03-28 |
| A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers (NCT05238207) | Bond Biosciences | 2022-03-28 |
| A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects (NCT05294458) | AstraZeneca | 2022-03-28 |
| Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults (NCT05377255) | Emergent BioSolutions | 2022-03-28 |
| Assessment of Abuse Potential of Cebranopadol in Humans (NCT05256108) | Tris Pharma, Inc. | 2022-03-28 |
| Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer (NCT05143229) | University of Kansas Medical Center | 2022-03-28 |
| 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer (NCT05286840) | Luke Nordquist, MD | 2022-03-28 |
| Phase I Norovirus Challenge Model (NCT04174560) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-28 |
| A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration (NCT05274516) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2022-03-28 |
| Phase I Study of GN-037 Cream for Psoriasis (NCT05428202) | TC Erciyes University | 2022-03-28 |
| Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC) (NCT05280717) | Vir Biotechnology, Inc. | 2022-03-28 |
| A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas (NCT05279300) | CStone Pharmaceuticals | 2022-03-28 |
| Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease (NCT05197712) | Baiya Phytopharm Co., Ltd. | 2022-03-28 |
| A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine. (NCT05314283) | Novo Nordisk A/S | 2022-03-28 |
| A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib (NCT05262751) | Boehringer Ingelheim | 2022-03-28 |
| A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) (NCT05155332) | Boehringer Ingelheim | 2022-03-28 |